CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.

Scan to Download iOS&Android APP

Handel Pluri Inc. - PLUR CFD

1.0587
5.36%
  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.0326
Long position, gebyr natten over

Long position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.030779%
Short position, gebyr natten over

Short position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.013666%
Gebyr natten over, tid 22:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Nøglestatistikker
Tidligere luk* 1.1187
Åben* 1.1187
1-Års Ændring* -33.01%
Dagens Spænd* 1.0587 - 1.1287
52-Ugers Spænd 0.65-2.21
Gennemsnitlig Volumen (10 dage) 30.38K
Gennemsnitlig Volumen (3 måneder) 1.47M
Market Cap 34.94M
P/E-forhold -100.00K
Udestående aktier 32.66M
Omsætning 321.00K
EPS -1.12
Dividend (Udbytte %) N/A
Beta 1.60
Næste indtjeningsopgørelse N/A

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Feb 3, 2023 1.0587 -0.0600 -5.36% 1.1187 1.1287 1.0587
Feb 2, 2023 1.1187 0.0200 1.82% 1.0987 1.1187 1.0787
Jan 27, 2023 1.1187 -0.0299 -2.60% 1.1486 1.1586 1.1087
Jan 26, 2023 1.1287 0.0100 0.89% 1.1187 1.1287 1.1187
Jan 25, 2023 1.0887 0.0000 0.00% 1.0887 1.0887 1.0887
Jan 24, 2023 1.1586 0.0000 0.00% 1.1586 1.1686 1.1586
Jan 20, 2023 1.1586 -0.0400 -3.34% 1.1986 1.1986 1.1586
Jan 19, 2023 1.2286 0.0200 1.65% 1.2086 1.2585 1.1686
Jan 18, 2023 1.2785 0.0599 4.92% 1.2186 1.2785 1.2186
Jan 17, 2023 1.2585 0.0799 6.78% 1.1786 1.3285 1.1786
Jan 13, 2023 1.2086 0.1399 13.09% 1.0687 1.3984 1.0687
Jan 12, 2023 1.0288 0.0000 0.00% 1.0288 1.0687 1.0288
Jan 11, 2023 1.0088 -0.0200 -1.94% 1.0288 1.0288 1.0088
Jan 9, 2023 1.0288 0.0300 3.00% 0.9988 1.0588 0.9988
Jan 6, 2023 0.9986 0.0435 4.55% 0.9551 1.0288 0.9551
Jan 5, 2023 0.9550 -0.0299 -3.04% 0.9849 0.9850 0.9489
Jan 4, 2023 0.9987 0.0039 0.39% 0.9948 0.9988 0.9948
Jan 3, 2023 0.9916 0.0067 0.68% 0.9849 0.9985 0.9788
Dec 30, 2022 0.9352 -0.0065 -0.69% 0.9417 0.9489 0.9352
Dec 29, 2022 0.9277 -0.0175 -1.85% 0.9452 0.9551 0.9203

Pluri Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Total omsætning 2.847 0 0.05 0.054 0.023 0
Omsætning 2.847 0 0.05 0.054 0.023 0
Kost af omsætning, Total 0.1 0 0.002 0.002 0 0
Bruttofortjeneste 2.747 0 0.048 0.052 0.023 0
Totale Driftsudgifter 26.166 28.019 33.781 35.586 29.499 50.623
Salgs/Generelle/Admin. Udgifter, Total 6.486 6.927 11.193 9.157 7.922 20.557
Forskning & Udvikling 20.85 21.972 24.478 12.841 21.643 13.47
Depreciation / Amortization 2.006 2.029 1.893 1.841 1.453 1.252
Other Operating Expenses, Total -3.276 -2.909 -3.785 11.745 -1.519 15.344
Driftsindtægter -23.319 -28.019 -33.731 -35.532 -29.476 -50.623
Renteindkomst (Udgift), Netto Ikke-Drift 0.109 0.272 8.542 0.105 0.356 0.781
Andre, Netto -0.036 -0.067 -0.937 0.12 -0.032 -0.023
Netto Indkomst Før Skat -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Netto Indkomst Efter Skat -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Netto Indkomst Før Ekstra Ting -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Netto Indkomst -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Fortyndet Netto Indkomst -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Fortyndet Vægtet Gennemsnit Aktier 7.9548 8.74262 10.5877 1.23329 18.1973 28.1136
Fortyndet EPS Uden Ekstraordinære Ting -2.92226 -3.18143 -2.46759 -28.6283 -1.602 -1.77369
Dividends per Share - Common Stock Primary Issue 0
Fortyndet Normaliseret EPS -2.85237 -3.12149 -2.38995 -28.1158 -1.5688 -1.74709
Q3 2021 Q4 2021 Q1 2021 Q2 2021 Q3 2022
Total omsætning 0 0 0 0 0.234
Omsætning 0 0 0.234
Kost af omsætning, Total 0 0
Bruttofortjeneste 0 0
Totale Driftsudgifter 14.225 14.587 11.441 10.795 10.709
Salgs/Generelle/Admin. Udgifter, Total 6.559 6.102 5.088 4.288 4.553
Forskning & Udvikling 7.824 8.507 6.391 6.541 6.273
Other Operating Expenses, Total -0.158 -0.022 -0.038 -0.034 -0.117
Driftsindtægter -14.225 -14.587 -11.441 -10.795 -10.475
Renteindkomst (Udgift), Netto Ikke-Drift -0.029 0.019 0.009 -0.145 0.557
Netto Indkomst Før Skat -14.254 -14.568 -11.432 -10.94 -9.918
Netto Indkomst Efter Skat -14.254 -14.568 -11.432 -10.94 -9.918
Netto Indkomst Før Ekstra Ting -14.254 -14.568 -11.432 -10.94 -9.918
Netto Indkomst -14.254 -14.568 -11.432 -10.94 -9.918
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -14.254 -14.568 -11.432 -10.94 -9.918
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -14.254 -14.568 -11.432 -10.94 -9.918
Fortyndet Netto Indkomst -14.254 -14.568 -11.432 -10.94 -9.918
Fortyndet Vægtet Gennemsnit Aktier 29.6172 31.6441 32.0008 32.1363 32.2616
Fortyndet EPS Uden Ekstraordinære Ting -0.48127 -0.46037 -0.35724 -0.34042 -0.30742
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -0.48127 -0.46037 -0.35724 -0.34042 -0.30742
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Totale Nuværende Aktiver 35.596 29.016 32.036 26.371 48.461 67.371
Likvider og Kortsigtede Investeringer 32.208 26.106 29.9 23.705 45.784 64.95
Likvider & Lignende 6.223 4.707 8.821 4.106 8.27 31.241
Kortsigtede Investeringer 25.985 21.399 21.079 19.599 37.514 33.709
Totale Tilgodehavender, Netto 2.481 1.174 0.847 1.421 1.61 1.49
Accounts Receivable - Trade, Net 2.251 1.036 0.69 1.243 1.248 1.108
Prepaid Expenses 0.3 0.882 0.602 0.532 0.445 0.333
Other Current Assets, Total 0.607 0.854 0.687 0.713 0.622 0.598
Total Assets 45.941 37.534 38.96 31.31 65.532 93.538
Property/Plant/Equipment, Total - Net 9.216 7.277 5.678 3.838 3.775 2.227
Property/Plant/Equipment, Total - Gross 17.183 16.507 16.893 17.004 18.437 18.259
Accumulated Depreciation, Total -7.967 -9.23 -11.215 -13.166 -14.662 -16.032
Long Term Investments 0.363 0.403 0.383 0.398 12.653 23.269
Other Long Term Assets, Total 0.766 0.838 0.863 0.703 0.643 0.671
Total Current Liabilities 5.775 5.414 8.548 8.158 7.987 11.517
Accounts Payable 2.705 1.966 3.261 2.281 1.968 2.526
Accrued Expenses 2.819 3.106 4.164 5.637 5.893 8.951
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 0.251 0.342 1.123 0.24 0.126 0.04
Total Liabilities 7.785 7.283 10.453 9.489 9.431 36.387
Total Long Term Debt 0 0 0 0 0 23.85
Other Liabilities, Total 2.01 1.869 1.905 1.331 1.444 1.02
Total Equity 38.156 30.251 28.507 21.821 56.101 57.151
Common Stock 0.001 0.001 0.001 0.001
Additional Paid-In Capital 198.432 217.822 244.203 272.824 336.257 387.172
Retained Earnings (Accumulated Deficit) -161.757 -189.571 -215.697 -251.004 -280.156 -330.021
Unrealized Gain (Loss) 1.48 1.48 8.44
Other Equity, Total 0 0.519 -8.44
Total Liabilities & Shareholders’ Equity 45.941 37.534 38.96 31.31 65.532 93.538
Total Common Shares Outstanding 8.0269 9.69388 11.3566 15.0829 25.4927 31.9578
Long Term Debt 23.85
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Totale Nuværende Aktiver 49.82 67.371 62.826 60.153 64.313
Likvider og Kortsigtede Investeringer 47.37 64.95 60.671 58.183 61.98
Likvider & Lignende 12.265 31.241 14.611 18.715 23.791
Kortsigtede Investeringer 35.105 33.709 46.06 39.468 38.189
Other Current Assets, Total 2.45 2.421 2.155 1.97 2.333
Total Assets 79.174 93.538 83.747 81.184 79.127
Property/Plant/Equipment, Total - Net 2.713 2.227 1.749 9.331 9.14
Long Term Investments 25.937 23.269 18.483 10.965 4.235
Other Long Term Assets, Total 0.704 0.671 0.689 0.735 1.439
Total Current Liabilities 9.916 11.517 10.365 9.595 7.822
Accounts Payable 2.11 2.526 3.723 4.058 3.942
Accrued Expenses 5.613 6.575 6.642 5.537 3.88
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 2.193 2.416
Total Liabilities 11.038 36.387 34.84 41.344 41.034
Total Long Term Debt 0 23.85 23.444 23.158 22.924
Other Liabilities, Total 1.122 1.02 1.031 8.591 8.238
Total Equity 68.136 57.151 48.907 39.84 38.0933
Additional Paid-In Capital 383.589 387.172 390.36 392.233 400.351
Retained Earnings (Accumulated Deficit) -315.453 -330.021 -341.453 -352.393 -362.258
Total Liabilities & Shareholders’ Equity 79.174 93.538 83.747 81.184 79.1273
Total Common Shares Outstanding 31.7402 31.9578 32.0969 32.2251 32.3424
Totale Tilgodehavender, Netto 0
Accounts Receivable - Trade, Net 0
Current Port. of LT Debt/Capital Leases 0
Long Term Debt 23.85 23.444 23.158 22.924
Common Stock 0.00032 0.00032
Other Equity, Total -0.00032
Minority Interest 2.05
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Netto indkomst/Startlinje -23.246 -27.814 -26.126 -35.307 -29.152 -49.865
Likvider Fra Driftsaktiviteter -18.522 -21.611 -21.38 -29.453 -26.369 -30.91
Likvider Fra Driftsaktiviteter 2.15 2.177 2.018 1.962 1.57 1.37
Ikke-Likvide Ting 3.498 4.174 -1.025 5.146 2.562 13.968
Cash Taxes Paid 0.066 0.028 0.027 0.01 0.01
Ændringer i Driftskapital -0.924 -0.148 3.753 -1.254 -1.349 3.617
Likvider fra Investeringsaktiviteter 1.312 4.355 5.681 1.17 -30.458 -7.265
Kapitaludgifter -1.75 -0.378 -0.342 -0.239 -0.27 -0.373
Andre Investerings-Cash-Flow-Ting, Total 3.062 4.733 6.023 1.409 -30.188 -6.892
Likvider fra Financieringsaktiviteter 0.807 15.797 19.921 23.582 60.87 61.402
Udstedelse (Pensionering) af Aktier, Netto 0.807 15.728 19.833 23.475 60.87 36.953
Netto Ændring i Likviditet -16.403 -1.459 4.222 -4.701 4.043 22.609
Financiering af Cash-Flow-Ting 0.069 0.088 0.107 0
Udstedelse (Pensionering) af Gæld, Netto 24.449
Udenlandsk Børs Effekter -0.618
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -35.297 -49.865 -11.432 -22.372 -32.29
Cash From Operating Activities -21.313 -30.91 -8.789 -18.652 -28.074
Cash From Operating Activities 1.034 1.37 0.337 0.664 0.915
Non-Cash Items 10.382 13.968 3.188 6.1 7.782
Cash Taxes Paid 0.008
Changes in Working Capital 2.568 3.617 -0.882 -3.044 -4.481
Cash From Investing Activities -12.057 -7.265 -7.24 7.075 14.738
Capital Expenditures -0.331 -0.373 -0.015 -0.044 -0.081
Other Investing Cash Flow Items, Total -11.726 -6.892 -7.225 7.119 14.819
Cash From Financing Activities 36.992 61.402 0 0 7.5
Issuance (Retirement) of Stock, Net 36.992 36.953 0 0 0
Net Change in Cash 3.622 22.609 -16.62 -12.616 -6.908
Issuance (Retirement) of Debt, Net 24.449
Foreign Exchange Effects -0.618 -0.591 -1.039 -1.072
Financing Cash Flow Items 7.5
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
Yanay (Yaky) Individual Investor 3.2937 1075620 396790 2022-12-22 LOW
Regals Capital Management, L.P. Investment Advisor 3.2824 1071938 1071938 2022-01-24
Aberman (Zalman) Individual Investor 2.5434 830604 -2000 2022-12-20 LOW
Slager (David M) Individual Investor 1.8774 613100 613100 2022-01-24 HIGH
Meitav Dash Investments Ltd. Investment Advisor 0.5132 167593 0 2022-09-30 LOW
Nia Impact Capital Investment Advisor 0.4071 132947 -318394 2022-09-30 LOW
Susquehanna International Group, LLP Investment Advisor 0.3235 105657 -174105 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 0.3197 104400 -2900 2022-09-30 HIGH
Bridgeway Capital Management, LLC Investment Advisor 0.3142 102600 -10000 2022-09-30 LOW
Nikko Asset Management Americas, Inc. Investment Advisor/Hedge Fund 0.2574 84056 -20865 2021-12-31 LOW
Franco-Yehuda (Chen) Individual Investor 0.225 73466 6875 2022-12-21 LOW
Green Alpha Advisors, LLC Investment Advisor 0.1794 58603 2377 2022-12-31 HIGH
Values First Advisors, Inc. Investment Advisor 0.1398 45653 -2677 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.1211 39544 0 2022-12-31 LOW
Jane Street Capital, L.L.C. Research Firm 0.1102 35986 -46524 2022-09-30 HIGH
Group One Trading, L.P. Research Firm 0.0877 28638 -5900 2022-09-30 HIGH
Zürcher Kantonalbank (Asset Management) Bank and Trust 0.0842 27497 -137 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.0771 25169 0 2022-09-30 LOW
Millennium Management LLC Hedge Fund 0.0625 20412 -120303 2022-09-30 HIGH
Archford Capital Strategies, LLC Investment Advisor 0.0401 13091 0 2022-12-31 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group
+485000+

Handlende

65000+

Månedlkige, aktive klienter

$48000000+

Månedlig investeringsvolumen

$28000000+

Hævet hver måned

Handelslommeregner

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Handelskurtage
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Gearing
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long

Pluri Inc. Company profile

Om Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc. er en udvikler af placentabaserede celleterapi produktkandidater til behandling af flere ischæmiske, inflammatoriske og hæmatologiske tilstande. Selskabets hovedindikationer er kritisk lemiskæmi (CLI), genopretning efter operation for lårhalsbrud og akut strålingssyndrom. Virksomhedens aktiviteter er fokuseret på forskning, udvikling, kliniske forsøg og fremstilling af celleterapeutika og relaterede teknologier. Virksomhedens produkter omfatter PLX-PAD og PLX R18. Selskabets PLX-celler er adhærente stromaceller (ASC'er), der ekspanderes ved hjælp af en tredimensionel (3D) proces. Systemet anvender et syntetisk stillads til at skabe et kunstigt 3D-miljø, hvor placentaafledte stromale celler kan vokse. Virksomhedens PLX-produkter administreres ved hjælp af en standardnål og -sprøjte. Selskabets PLX-produkter er i den kliniske udviklingsfase for flere forskellige indikationer, f.eks. kardiovaskulære, ortopædiske, lungesygdomme og kvindesygdomme.

Industry: Biotechnology & Medical Research (NEC)

MATAM Advanced Technology Park
Building #5
3508409

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Long position, gebyr natten over -0.0223%
Short position, gebyr natten over 0.0065%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.03

US100

12,566.80 Price
-0.450% 1D Chg, %
Long position, gebyr natten over -0.0183%
Short position, gebyr natten over 0.0071%
Gebyr natten over, tid 22:00 (UTC)
Spænd 3.0

XRP/USD

0.41 Price
-0.880% 1D Chg, %
Long position, gebyr natten over -0.0500%
Short position, gebyr natten over 0.0140%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.00327

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Long position, gebyr natten over -0.1138%
Short position, gebyr natten over 0.0796%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.005

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel